Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Merkle

Showing results (21-30 of 69) with videos related to

Pageof 7
Sort By:
Rontgenpraxis; Zeitschrift Fur Radiologische Technik|May 1, 1996
[Malignant schwannoma of the abdomen]S C Krämer, O Kolokythas, A J Aschoff, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|December 1, 1996
[Presentation of a new self-expanding vascular spiral stent]N Rilinger, J Görich, E Merkle, et al.
Geburtshilfe Und Frauenheilkunde|December 1, 1994
[Immunocytochemical detection of tumor cells in bone marrow as a prognostic factor in breast carcinoma]E Merkle, J Bähr, A Henke, et al.
Journal of Computer Assisted Tomography|September 19, 1997
MRI of histologically confirmed mammary carcinoma: clinical relevance of diagnostic procedures for detection of multifocal or contralateral secondary carcinomaA Rieber, E Merkle, W Böhm, et al.
Geburtshilfe Und Frauenheilkunde|March 1, 1990
[Adjuvant chemotherapy of breast cancer with the CMFV protocol]E Merkle, C Seidl, U Fuchs, et al.
European Journal of Cancer (Oxford, England : 1990)|July 2, 2002
Factors influencing the prognostic role of oestrogen and progesterone receptor levels in breast cancer--results of the analysis of 670 patients with 11 years of follow-upS-D Costa, S Lange, K Klinga, et al.
European Radiology|January 1, 1997
Oral administration of iopentol (Imagopaque 300 mg I/ml) compared with amidotrizoate (Peritrast 300 mg I/ml), both diluted to 2% (v/v), in imaging of the gastrointestinal tract in abdominal contrast enhanced CT. A clinical trial assessing patient tolerance, distribution of contrast medium and Hounsfield unit measurementsJ M Friedrich, K Skinningsrud, C Welter, et al.
Rontgenpraxis; Zeitschrift Fur Radiologische Technik|June 1, 1997
[Avascular bone necrosis]R Tomczak, A Rieber, E Merkle, et al.
Infection Control and Hospital Epidemiology|June 14, 2011
An alternate approach to improving healthcare worker influenza vaccination ratesLisa M Esolen, Kimberly L Kilheeney, Richard E Merkle, et al.
The British Journal of Radiology|March 1, 1996
Computer assisted determination of the dose-area product in retrograde urethrographyE Merkle, A J Aschoff, M Müller, et al.
Pageof 7

Showing results (21-30 of 69) with videos related to

Sort By:
Pageof 7
Rontgenpraxis; Zeitschrift Fur Radiologische Technik|May 1, 1996
[Malignant schwannoma of the abdomen]S C Krämer, O Kolokythas, A J Aschoff, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|December 1, 1996
[Presentation of a new self-expanding vascular spiral stent]N Rilinger, J Görich, E Merkle, et al.
Geburtshilfe Und Frauenheilkunde|December 1, 1994
[Immunocytochemical detection of tumor cells in bone marrow as a prognostic factor in breast carcinoma]E Merkle, J Bähr, A Henke, et al.
Journal of Computer Assisted Tomography|September 19, 1997
MRI of histologically confirmed mammary carcinoma: clinical relevance of diagnostic procedures for detection of multifocal or contralateral secondary carcinomaA Rieber, E Merkle, W Böhm, et al.
Geburtshilfe Und Frauenheilkunde|March 1, 1990
[Adjuvant chemotherapy of breast cancer with the CMFV protocol]E Merkle, C Seidl, U Fuchs, et al.
European Journal of Cancer (Oxford, England : 1990)|July 2, 2002
Factors influencing the prognostic role of oestrogen and progesterone receptor levels in breast cancer--results of the analysis of 670 patients with 11 years of follow-upS-D Costa, S Lange, K Klinga, et al.
European Radiology|January 1, 1997
Oral administration of iopentol (Imagopaque 300 mg I/ml) compared with amidotrizoate (Peritrast 300 mg I/ml), both diluted to 2% (v/v), in imaging of the gastrointestinal tract in abdominal contrast enhanced CT. A clinical trial assessing patient tolerance, distribution of contrast medium and Hounsfield unit measurementsJ M Friedrich, K Skinningsrud, C Welter, et al.
Rontgenpraxis; Zeitschrift Fur Radiologische Technik|June 1, 1997
[Avascular bone necrosis]R Tomczak, A Rieber, E Merkle, et al.
Infection Control and Hospital Epidemiology|June 14, 2011
An alternate approach to improving healthcare worker influenza vaccination ratesLisa M Esolen, Kimberly L Kilheeney, Richard E Merkle, et al.
The British Journal of Radiology|March 1, 1996
Computer assisted determination of the dose-area product in retrograde urethrographyE Merkle, A J Aschoff, M Müller, et al.
Pageof 7